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The progression from primary Mycobacterium tuberculosis infection to disease is usually slow in humans.
The aim of this study was to develop and characterize a mouse model for slowly progressive primary
tuberculosis, using the intraperitoneal (i.p.) route of infection, and to compare it with our previously described
model of latent M. tuberculosis infection. B6D2F1 hybrid mice inoculated with 1.5 · 106 colony-forming units
(CFUs) of M. tuberculosis H37Rv were followed-up for 70 weeks. Lungs, livers and spleens were examined
for bacillary growth, histopathological changes and mycobacterial antigens (MPT64, ManLAM and multiple
antigens of M. tuberculosis), by immunohistochemical staining. The infection was found to pass through three
distinctive phases. During phase 1, mice were healthy despite development of small granulomas and an
increasing number of bacilli in the lungs. During phase 2, mice were unwell but mortality was low. The count
of M. tuberculosis and the granuloma size stabilized. The granulomas contained an increasing population
of large, vacuolated macrophages. During phase 3, mice became moribund and died rapidly, but the
M. tuberculosis count remained relatively stable. The inflammatory infiltrates filled < 80% of the lung
parenchyma and the lesions were not well demarcated. Rapidly progressing inflammation, rather than an
increase in the M. tuberculosis count, seems to contribute more to mortality.
Dr Tehmina Mustafa, Centre for International Health, Armauer Hansen building, Haukeland University
Hospital, N-5021 Bergen, Norway
INTRODUCTION
After infection with Mycobacterium tuberculosis in humans,
< 90% of the infected individuals mount a protective immune
response and remain clinically well, the only evidence of infec-
tion being development of a positive tuberculin test. In < 10% of
the infected individuals, the infection will progress to disease
[1,2]. The progression of primary infection to disease is slow in
humans. It is estimated that the majority (< 80%) of infected
individuals who develop disease will do so within the first 2 years
of infection [2–5]. As it is only a small proportion of infected
individuals who develop clinical disease, the risk factors for
infection may be quite different from the risk factors for clinical
disease following infection. Most of the studies in experimental
models in mice have focused on rapidly progressive disease after
inoculation with a high dose of M. tuberculosis [6,7], or treat-
ment with antituberculosis drugs (after initial infection and
renewed infection) to study memory immune response [8].
There are recent studies on slowly progressive infection in
lungs, by infecting the mice via intravenous (i.v.) [9,10] and
aerosol [11] routes.
We have previously established mouse models for latent
tuberculosis (TB) and rapidly progressive primary disease by
using the intraperitoneal (i.p.) route of infection [12]. After i.p.
injection, inert substances, radioactive materials, proteins and
bacteria are absorbed quickly (within 2 h in the case of bacteria),
drain first to the mediastinal lymph nodes and reach the lungs of
rat within 24 h [13–17]. The bacilli thus injected i.p. will initially
reach mediastinal lymph nodes, resembling natural airborne
infection. Airborne infection is undoubtedly the most appropriate
route of infection for mimicking human TB in an animal model.
It is, however, difficult to obtain complete control over the
desired dosage in mice when giving TB bacilli by the aerosol
route [18]. Bacilli that are trapped in the fur will be licked and
ingested, stimulate the gut-associated lymphoid tissue and modify
the immune response. Infection of mice by aerosol also poses a
hazard to the researchers, and it is necessary to have sophisti-
cated and expensive facilities [19].
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The aim of this study was to develop and characterize a mouse
model to study the natural course of slowly progressive disease
after primary infection using the i.p. route, and to compare this
model clinically, bacteriologically and histopathologically with
our previous models of latent infection and rapidly progressive
disease [12]. In our latent infection model, a low-to-moderate
dose (4 · 101– 4 · 105 bacilli) is given i.p. The mice do not
develop clinical disease or obvious pathology over a long
period of time and present no spontaneous reactivation of
disease. The number of M. tuberculosis bacilli (measured in
colony-forming units [CFUs]) is found to stabilize in the lung
and spleen after week 26. In the rapidly progressive disease
model, infection with a high dose (108) of bacilli gives a higher
bacterial count in the lungs, rapid development of disease, early
mortality and no recovery [12]. In the model of slowly progres-
sive primary TB, when 1.5 · 106 bacilli were given, the number
of bacteria stabilized in the lungs and spleens after week 20, but
the mice progressed slowly from subclinical infection to disease,
and later to morbidity and mortality.
MATERIALS AND METHODS
Mice. B6D2F1Bom (C57BL/6JBom · DBA/2JBom) female mice were
purchased from Bomholtga˚rd Breeding and Research Centre Ltd (Ry,
Denmark). All mice were < 12 weeks of age at the start of the
experiments. The average lifespan of these mice is 975 days. Animal
care was as described previously [12]. The experiments were performed
with the permission of the Norwegian Experimental Animal Board, and
Norwegian Law corresponds with the European Convention on the
Protection of Experimental Animals.
Bacteria. All experiments were conducted with the H37Rv strain of
M. tuberculosis. The stock bacillary suspension was prepared as
described previously [12]. Two hundred microlitres of phosphate-buf-
fered saline (PBS) containing < 1.5 · 106 CFU of M. tuberculosis were
inoculated i.p. into each mouse.
Experimental design. A total of 260 mice were infected. Six unin-
fected mice were kept, as sentinel controls, in cages with the infected
mice. No cross-infection was observed. Ten uninfected control mice
were kept under the same conditions as the infected mice, but in a
separate isolator, as controls for growth and age-related changes. Mice
were killed at 1, 2, 4 weeks and then at 4-weekly intervals up to week 41
and later at 52, 57 and 70 weeks after infection. At each time-point, mice
were selected at random, but at week 57, comparatively healthier mice
(eight mice) were selected.
Processing specimens for bacillary counts. A detailed procedure for
processing lungs, liver and spleen for bacillary counts has been described
previously [12]. Until week 24, one lung, one-half of spleen and liver
were analysed, from each mouse, for bacillary counts. From week 29
onwards, both lungs, whole spleen and liver were analysed from each
mouse. Ten-fold serially diluted tissue homogenates were plated on
Middlebrook 7H10 medium (Difco Laboratories, Detroit, MI, USA).
The plates were incubated at 37 8C, in an atmosphere of 5% CO2. The
reading of CFUs was discontinued when the counts remained unchanged
for three consecutive weeks. The maximum time the culture plates were
kept was 3 months after inoculation.
Tissue preparation for histopathology. One lung was fixed by immers-
ing one-half of it in 4% phosphate-buffered formaldehyde (pH. 7.3), and
the other half was frozen in isopentane prechilled with liquid nitrogen.
From week 29 onwards, perfusion of the lungs followed by fixation
was performed. The left lung was perfused with 4% buffered formalin,
fixed and embedded in paraffin. The right lung was perfused with a
mixture (1 : 1, v/v) of distilled water and Tissue-Tek (OCT compound,
Leica Mikroscopi AS, Oslo, Norway) before freezing. The frozen speci-
mens were embedded in OCT compound and stored at ¹ 70 8C until
sectioning.
For histological analysis, two 5-mm thick sections from each speci-
men were cut at 100-mm intervals, placed on the same glass slide and
stained with haematoxylin and eosin (H & E).
For detection of fibrosis, Sirius red stain for connective tissues was
used [20]. In brief, after hydration and washing in running water for
10 min, sections were stained in 0.1% picro-Sirius red F3BA, in
saturated aqueous picric acid solution, for 30 min (Sirius red F3BA-
Jurr; BDH, Laboratory Supplies, Poole, UK). After dehydration, tissues
were cleared in xylene and mounted.
Histological evaluation. The total area of a section and the area of
section occupied by the focal inflammatory infiltrates (granulomas) and
extensive inflammatory infiltrates after week 40 were measured. The
area of granuloma was measured in a Leitz Dialux 22 EB microscope
with · 1 and · 10 objective lens connected to a Sony CCD video camera
using the image-processing system Videoplan (Kontron Bild-analyse,
Eching, Germany). The total area of the section was measured by
projecting the sections onto paper using a projector (Carl Zeiss, Jena,
Germany) at a magnification of · 17. The drawings were measured on
the digitizer after calibration of the system using the image-processing
system. The degree of inflammation was determined by a ‘granuloma
fraction’ (GF).
GF ¼ Area of inflammatory infiltrate
Total area of the lung section
The area of inflammatory infiltrate was the granulomas and extensive
inflammatory infiltrates measured after week 40. The GF was calculated
for two sections from each mouse. At each time-point, the mean GF for
three to four mice was calculated.
Detection of mycobacterial antigens. Mycobacterial antigens were
detected by immunohistochemistry. The antibodies used were:
(1) anti (a)-MPT64, a polyclonal antibody reacting with a secreted
protein isolated from the early M. tuberculosis culture fluid [21,22];
(2) a-ManLAM, a polyclonal antibody reacting with mannose-capped
lipoarabinomannan, a cell wall component from M. bovis, bacillus
Calmette–Gue´rin (BCG) Copenhagen strain [23,24]; and
(3) a-BCG, a polyclonal antibody reacting with multiple antigens of
sonicate and culture fluid of M. bovis BCG Copenhagen strain (Dako A/
S, Copenhagen, Denmark) [25,26].
M. bovis BCG and M. tuberculosis are extensively similar in their
antigenic content [27]. Anti-BCG is expected to react with multiple
antigens of M. tuberculosis. The antigens detected by a-BCG were
designated as mycobacterial antigens.
Formalin-fixed paraffin-embedded tissues were studied for the pre-
sence of mycobacterial antigens. The fixation process leads to formation
of complex aldehyde-linked protein aggregates in which primary and
secondary protein structures might be preserved, while the tertiary or
quaternary protein structures are altered by extensive cross-linking.
Therefore the accessibility of antigenic epitopes might be limited.
Such hindrances may be partially reversed by retrieval techniques like
enzyme digestion and microwave oven heating [28–30]. To identify a
suitable method for antigen retrieval, the effect of pretreatment with
enzyme and microwave oven heating was studied in tissues from eight
mice in the following three experiments:
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(1) enzyme pretreatment, where tissues were treated with 0.1% trypsin
in tris phosphate-buffered saline (TBS) for 10 and 20 min;
(2) microwave pretreatment, where slides were placed in citrate buffer
solution, pH 6.0 (Dako A/S), and heated in a microwave oven (Miele
electronic M696, Germany) for 5 and 10 min at 700 W; and
(3) a combination of enzyme and microwave pretreatments.
From these experiments, enzyme pretreatment for 20 min was found
to give the best results for antigen retrieval.
Frozen tissues were studied for the detection of MPT64, ManLAM
and mycobacterial antigens at the time-points shown in Table 1.
The immunohistochemical method of staining has already been
described [12]. Briefly, the formalin-fixed paraffin-embedded sections
were deparaffinized and treated with the enzyme before incubation,
while the frozen sections were fixed in cold acetone for 10 min.
Endogenous peroxidase activity was blocked with H2O2. Sections
were also pretreated with avidin and biotin-blocking solution in order
to reduce endogenous biotin staining (Vector Laboratories, Burlingame,
AL, USA). To block nonspecific binding mainly with Fc receptors,
incubation was carried out using swine serum. Sections were then
incubated overnight with primary antibody. Incubation with biotinylated
swine antirabbit immunoglobulin G (Dako A/S) followed by incubation
with avidin–biotin–peroxidase complex (ABC; Dako A/S) was carried
out. Location of antigen was visualized by incubating sections with
H2O2 and 3-amino-9-ethylcarbazol-containing buffer. The sections
were washed in TBS between each incubation. The slides were counter-
stained slightly with Mayer’s haematoxylin. As a negative control,
1% bovine serum albumin (BSA)/TBS was used instead of primary
antibody.
Evaluation of immunostaining. For the evaluation of mycobacterial
antigen load, three to four mice were analysed at each time-point.
The antigen-containing cells were enumerated by light microscopy
as:
(1) total number of antigen-positive cells/mm2 of the lung tissue from
each mouse. The whole lung section was counted; and
(2) percentage of mycobacterial antigen-positive cells, evaluated
using a · 40 ocular fitted with a 10 · 10 mm graticule. The antigen-
positive cells and the total number of nucleated cells were counted for
each field. For each specimen, three to four fields were counted from the
inflammatory area.
Survival analysis. Late in the experiment, the mice were moribund. To
reduce their suffering, these moribund mice were killed after week 47
according to a fixed set of exclusion criteria, as it was observed that mice
fulfilling these criteria died within 24–48 h. Seven characteristics,
namely body form (normal—thin cachectic), spine form (normal—
lordosis or kyphosis), appearance of coat (flat—raised pelt), gait (flat—
toeing), activity (active—passive), behaviour (running—immobile) and
abdominal muscles (flat abdomen—guarding) were used. Each char-
acteristic was given a score of 5 to 1, according to severity, 1 being
the worst. Mice that had a score of 1 in four characteristics, including
cachexia, were considered moribund and were killed. These killed
mice were considered as spontaneously dead. Among 143 dead mice,
24 deaths occurred between weeks 40 and 47 and were not recorded
by exact dates. These deaths were distributed equally over these
weeks.
Statistical analysis. For survival analysis the Kaplan–Meier model
was used [31]. This analysis was performed using the software program
SPSS (SPSS, Inc., Chicago, IL, USA). This is a method of estimating
time-to-event models in the presence of censored cases.
The Mann–Whitney U-test was used for two-group comparisons.
Statistical significance was defined as a P-value < 0.05.
RESULTS
Clinical status of mice
Mice stayed healthy until week 16 after infection. Thereafter, the
mice started developing signs of illness. Between weeks 20–40
the mice were unwell, but mortality was low. By week 30, 7% of
the mice had died. Around week 40, the majority of mice became
moribund and started dying rapidly. Figure 1 shows the survival
curve for the whole observation period. The last death recorded
was in week 70. The remaining 16 mice were killed at weeks 70
and 74.
Lungs
As evaluated using gross pathology, the lungs appeared normal
until week 4 after infection. At weeks 8 and 12 the killed mice
had pink, air-containing lungs of normal size, speckled with grey
lesions varying in number and size but always relatively small.
At week 16, one or two whitish-yellow nodules per lung
appeared besides grey-black small nodules. From week 20
onwards, the nodules were whitish-yellow surrounded by a
greyish-blue zone, and were harder than the surrounding lung
tissue. The nodules increased in number and size. At week 37 the
nodules appeared smaller, more like the nodules from the week
20 specimens. However, in one mouse, most of the lung tissue
was whitish-yellow, hard and consolidated by confluence of the
nodules. After week 41, the nodules were all confluent, merging
into larger whitish-yellow and hard areas.
The GF (as defined in the Materials and methods) is shown in
Fig. 2. The granulomas increased in size with progression of time
from week 4 until week 16. From week 20 until week 37, the
granuloma size remained relatively unchanged. From week 37 to
week 41 there was a sudden increase in granuloma size, filling
< 80% of the lung sections; it then remained quite stable for the
rest of the experimental period.
One and two weeks after infection, there was diffuse infiltra-
tion of inflammatory cells in the alveolar-capillary interstitium in
some areas of the lung parenchyma, as observed using light
microscopy. The cells were mainly lymphocytes and macro-
phages, together with a few polymorphonuclear cells (PMNs).
The blood vessels in the interstitium were dilated. The alveolar
spaces did not contain any inflammatory cells. After week 4, the
lungs showed focal infiltrates of inflammatory cells (granulo-
mas). The granulomas were small and contained predominantly
macrophages and lymphocytes. A few PMNs were also present.
The lymphocytes and PMNs were usually seen around blood
vessels as well as distributed in the whole granuloma (Fig. 3A,B).
These early granulomas, where the macrophages were mixed
with the lymphocytes, were categorized as mixed granulomas
(MG). At week 4, all the infiltrates were MG.
With progression of time, the granulomas increased both in
number and size. The distribution of macrophages and lymphocytes
became more defined in the granulomas (Fig. 3C,D). The macro-
phages increased in size and attained a vacuolated appearance
(light staining vesicular nuclei, increased vacuolated eosinophilic
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cytoplasm), and demonstrated a syncytial appearance. Few lym-
phocytes and pyknotic bodies were seen (Fig. 3D). These areas
were called macrophage aggregates. The lymphocytes were initi-
ally more scattered in the granuloma, but gradually formed loose
aggregates called lymphocyte aggregates. PMNs were found
scattered in the macrophage and lymphocyte aggregates and
more so in the vicinity of pyknotic bodies. These granulomas,
with a differential distribution of macrophages and lymphocytes,
were categorized as differentiated granulomas (DG). At weeks 8
and 12, the infiltrates were of both MG and DG types, with
dominance of MG at week 8 and of DG at week 12. With
Sirius red staining, delicate fibrils were seen in the lesions from
week 12.
From week 16 onwards, all the infiltrates were of the DG type.
In the macrophage aggregates, groups of degenerated cells were
seen. Fibroblasts appeared around the groups of degenerated
cells. Collagen and reticular fibres that were dispersed in the
granulomas increased and appeared mature and thicker com-
pared with earlier time-points. With progression of time there
was an increase in the number of degenerated cells, fibrous tissue
and PMNs in the macrophage aggregates. At weeks 33 and 37,
in the lungs of four out of six mice the inflammatory response
was focal. However, in two mice, there was an extensive spread
of the inflammatory infiltrate involving < 70% of the lung
parenchyma.
From week 41 onwards, the mice exhibited a shift in the
histopathology. The inflammatory infiltrates were no longer
distinctly focal and there was a significant increase in the size
of the inflammatory infiltrates compared with weeks 20–37
(P ¼ 0.0001). Extensive diffuse inflammatory infiltrates occu-
pied 70–80% of the lung parenchyma (Fig. 2 & Fig. 3E). This
increase in the size of infiltrates was due to an increase in the
number of vacuolated macrophages. The lymphocyte aggregates
were reduced in size (Fig. 3E,F). The number of fibroblasts was
increased but there was no significant increase in the collagen
and reticular fibres compared with weeks 20–37. After week 40,
the majority of the mice were moribund but some mice were less
unwell. At week 57, the less unwell mice were killed. At week
70, because of the killing and death of moribund mice, the less
unwell mice were selected. The moribund mice at weeks 41 and
52 had focal areas of cellular debris (Fig. 3G). These areas fused
to form large foci of necrosis (Fig. 3H). There were markedly
few lymphocytes. The bronchiolar lumen contained the cellular
debris. The mice that were less unwell had no such focal areas of
cellular debris and the lymphocyte aggregates were larger than in
the moribund mice.
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Fig. 1. Survival of mice with slowly
progressive primary tuberculosis. Analysis
was performed using the Kaplan–Meier
model in SPSS. The killed mice (X) were
censored from the analysis.
Fig. 2. Granuloma fraction (GF) in the lungs
of mice with slowly progressive primary
tuberculosis. The GF was defined as
described in the Materials and methods. In
each group, n ¼ 3 or 4 mice. Bars indicate
the standard error of the mean (SEM).
Significant differences were observed
between weeks 4–16 and weeks 20–37
(*P ¼ 0.0001) and between weeks 20–37
and weeks 41–70 (**P ¼ 0.0001).
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Mycobacterial antigens in the tissues
Mycobacterial antigens were not detected in formalin-fixed lung
tissue sections until week 8 after infection. Antigens were
detectable only in the macrophages in the granulomatous lesions.
Within different granulomas in the same lung section, the antigen
distribution varied. At week 8, < 50%, and between weeks 12
and 20, < 75% of the granulomas contained detectable antigens.
From week 24 onwards almost all the granulomas contained
antigens.
Figure 4 shows the total number of mycobacterial antigen-
positive cells (stained cells)/mm2 of the lung section. The number
of stained cells varied among the positively stained granulomas
in the same lung section. Some granulomas contained very high
numbers of stained cells compared with others, even though the
size, cellular components and morphology of the granulomas
were not so different. The number of stained cells was, however,
not significantly different between the groups of mice, killed at
each time-point, up to week 20. At weeks 24 and 29, the number
of stained cells was significantly higher than at earlier time-
points. At weeks 33 and 37, the number of stained cells decreased
to the same level observed at week 20. At weeks 41 and 52, the
moribund mice had a significantly higher number of stained cells
compared with (week 57 and 70) mice that were less unwell
(P ¼ 0.045). The total number of stained cells varied during the
course of infection but the percentage of stained cells (3–7%)
remained relatively stable.
Macrophages staining positively for mycobacterial antigens
seemed to contain highly variable amounts of antigen. Figures 5
and 6 show the different intensities and patterns of mycobacterial
antigen staining during the course of infection. The pattern of
staining was mainly granular and also sometimes diffuse. Rod-
shaped particles were rarely seen. The staining intensity was
recorded as weak, moderate or strong. Cells with all different
intensities of staining were present at all time-points but with
varying frequency. At week 8 after infection, in MG, cells
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Fig. 3. Lung tissue, from mice with slowly
progressive primary tuberculosis, stained
with haematoxylin and eosin. (A) · 104 and
(B) · 416, mixed granuloma 4 weeks after
infection. Macrophages and lymphocytes are
mixed without any differentiation. (C) · 38
and (D) · 400, differentiated granuloma 20
weeks after infection. (C) Distribution of
macrophages and lymphocytes becomes
differentiated; macrophages form syncytia
and lymphocytes form loose aggregates. (D)
Macrophage aggregates showing vacuolated
macrophage syncytium formation. Few
lymphocytes and pyknotic bodies are seen.
(E–H), weeks 41–70 after infection. (E) · 40
and (F) · 400, the granulomas break down
and the inflammatory infiltrate disperses and
occupies < 80% of the lung parenchyma.
The lymphocyte aggregates are reduced. (F)
The vacuolated macrophages increased in
inflammatory infiltrates and lymphocytes are
found individually among the macrophages.
(G) · 100 to (H) · 40, the moribund mice at
weeks 41 and 52 developed multiple foci of
cellular debris. (H) The small foci fused to
form large foci of necrosis.
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staining with weak intensity (cells containing small and fine
granules) dominated (Fig. 5A,B). As the granulomas differen-
tiated, the vacuolated macrophages with moderate staining
intensity (cells containing bigger and coarser and a higher
number of granules than in weakly staining cells, but the
cytoplasm was not filled with antigen as in strongly staining
cells) dominated (Fig. 5C,D). From weeks 20–37, the majority
of macrophages stained with moderate and strong intensity
(cells were full of granules) (Fig. 5E,F). Antigen-containing
cells were found either singly or in groups of 3 to 15 cells.
With the progression of infection, groups of degenerating macro-
phages usually stained for antigens. However, some of the
antigen-loaded cells, usually present singly, did not show signs
of degeneration. In a granuloma, in spite of the same vacuolated
appearance of all the macrophages, only < 5% stained for
antigens. At weeks 57 and 70, in the less sick mice that had
fewer antigen-containing cells, cells staining with weak and
moderate intensity dominated (Fig. 6A,B), whereas the moribund
mice at weeks 41 and 52 had a higher number of antigen-
containing cells with predominance of moderate and strong
staining intensity (Fig. 6C,D). The necrotic foci contained
large amounts of antigens (Fig. 6E), and the bronchiolar lumen
containing cellular debris also exhibited antigen (Fig. 6F).
Table 1 shows the MPT64, ManLAM and mycobacterial
antigens detected in the frozen lung tissue. The level of all
antigens increased with progression of time. Before week 40, the
number of stained cells and intensity of stain for ManLAM and
mycobacterial antigens was similar. At week 29 and week 41 in
the moribund mice, there was a greater number of ManLAM-
containing cells than mycobacterial antigen-containing cells.
This could be because of an increase in the amount of
ManLAM in the tissues at weeks 29 and 41. The a-ManLAM
fraction in the a-BCG antiserum might not be able to detect
traces of ManLAM as efficiently as the specific a-ManLAM. The
number of mycobacterial antigen- and ManLAM-containing
cells were higher than MPT64-containing cells at week 41.
The MPT64-containing cells were present singly, as well as in
small groups, whereas the ManLAM-positive cells were present
mostly in groups (Fig. 6G,H).
A similar amount and pattern of mycobacterial antigens was
observed in paraffin sections and in frozen sections until week
20. At weeks 24, 29 and 41, when the load of antigen was high,
there was a greater number of cells containing mycobacterial and
ManLAM antigens in frozen sections than in paraffin sections
from the same animals. Deparaffinization of paraffin sections
might have removed some of the lipids.
The livers showed no gross pathology. Microscopically, a few
small foci of lymphocytes with few macrophages were seen in
mice with clinically severe disease. Spleens were enlarged but
did not contain detectable granulomas. Neither did the kidneys
contain any detectable granulomas.
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Fig. 4. Mycobacterial antigen-positive cells/
mm2 of the lung sections of mice with slowly
progressive primary tuberculosis.
Mycobacterial antigens were detected by
immunohistochemical staining of tissue
section with a-bacillus Calmette–Gue´rin (a-
BCG) polyclonal antibody. In each group,
n ¼ 3 or 4 mice. Bars indicate the standard
error of the mean (SEM). At each time-point
mice were chosen randomly for killing, but at
weeks 57 and 70 mice that were
comparatively less sick were selected. After
week 40, the differences between moribund
(weeks 41 and 52) and less sick (weeks 57 and
70) mice were significant (P ¼ 0.045).Weeks after infection
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Table 1. Semiquantitative analysis of the mycobacterial antigens
detected in the frozen lung sections by immunohistochemical staining
Frozen sections
Weeks after Mycobacterial
infection MPT64* ManLAM† antigens‡
8 ND ND þ
12 ND ND þ
16 ND ND þ
20 þ þþ þ
24 þþ þþ þ þ
29 ND þþ þ þ þ
41 þþ, þ þ þ þþ þ þ þ þþ
70 ND ND þ
Mycobacterial antigens were detected by polyclonal antibodies:
* a-MPT64, reacting with a secreted Mycobacterium tuberculosis pro-
tein; † a-ManLAM, reacting with mannose-capped lipoarabinomannan;
‡ a.-BCG, reacting with multiple antigens of M. bovis bacillus Calmette–
Gue´rin (BCG). M. bovis. BCG and M. tuberculosis are extensively
similar in their antigenic content, thus a-BCG is expected to react with
multiple antigens of M. tuberculosis.
þ, < 5; þ þ, 9–13; þþ þ, < 20; þþ þ þ, 25–40 stained cells/mm2
of lung section.
ND, not done.
Bacillary growth
Figure 7 shows the bacterial count (in CFUs) of M. tuberculosis
in the lung, liver and spleen during the course of infection. In the
lungs, at week 1 after inoculation, CFUs were the lowest among
the three organs. There was a progressive increase in CFUs in the
lungs until week 20. From week 20–37, the counts remained stable,
although higher than the earlier time-points (weeks 1–20) (P ¼
0.0001). At weeks 41 and 52, there was a further increase in the
CFUs. In less sick mice, at weeks 57 and 70, the CFUs were lower
compared with the moribund mice at weeks 41 and 52 (P ¼ 0.0008)
and were at the same level as in the stable period of weeks 20–37.
In the spleen and liver, there was an increase in CFUs from
weeks 1 to 2, and after that the CFUs gradually decreased. In
the spleen after week 12, and in the liver after week 16, there
was an increase in CFUs, corresponding with the time when the
mice started to become unwell. Subsequently, the CFUs were
stable in both organs. The CFUs in the spleen were higher than
in the liver throughout the course of infection. At the end of the
experiment, the CFUs in all the organs seemed to be similar to
those during the stable period (weeks 20–37).
DISCUSSION
In this study we established a mouse model of slowly progressive
primary TB by inoculating 1.5 · 106 bacilli i.p. and characterized
it clinically, histopathologically and bacteriologically. The
course of infection could be separated into three distinct
phases. During the first phase, mice were clinically healthy in
spite of development of small granulomas and rapid bacillary
growth in the lungs. In the second phase, mice were unwell but
mortality was low. The granuloma size and the CFUs remained
stable. During the third phase, there was a sudden increase in
mortality and morbidity and an explosive spread of inflammation
in most of the lung but with no substantial increase in CFUs.
The progression from disease (phase 2) to mortality (phase 3)
coincided with a shift from a focal, granulomatous host response
to a diffuse extensive inflammatory infiltrate involving 80% of
the lung parenchyma (Fig. 2). The bacterial count did not
increase substantially with the shift to phase 3 (Fig. 7). The
immune response of the host, rather than an increase in the
number of bacteria, seemed to determine the progression of
disease to mortality. A similar finding was made in our previous
study where mice with latent infection had no obvious lesions.
When these mice were challenged with corticosterone, extensive
inflammatory infiltrates developed in the lungs, coinciding with
disease and mortality, whereas the increase in bacterial number
was not significant [12]. This model has been studied further
for T-cell phenotypes and cytokines in situ to identify changes in
the cytokine profile or T cells that coincide with a shift in
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Fig. 5. Lung tissue from mice with slowly
progressive primary tuberculosis showing
mycobacterial antigens in formalin-fixed
paraffin-embedded tissue sections stained
with the avidin–biotin–peroxidase complex
(ABC). The antigens were detected by using
a-bacillus Calmette–Gue´rin (a-BCG)
polyclonal antiserum. Antigens were always
localized in the macrophages. (A–D), week
8 after infection: (A) · 184 and (B) · 448,
mixed granuloma with cells containing small
and fine granular staining (weak intensity
of stain); (C) · 176 and (D) · 440,
differentiated granuloma containing a higher
amount of antigen. Cells contain bigger and
coarser granules that do not fill the whole
cytoplasm (moderate intensity). (E) · 101
and (F) · 480, week 24 after infection: the
granulomas contain a higher level of
antigens compared with earlier time-points.
The cells staining with strong intensity
(arrow head) also appear beside those
staining with moderate intensity (arrow).
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Fig. 6. Lung tissue from mice with slowly
progressive primary tuberculosis showing
mycobacterial antigens stained with the
avidin–biotin–peroxidase complex (ABC),
during weeks 41–70 after infection, in
(A–F) formalin-fixed paraffin-embedded and
(G–H) frozen sections. At each time-point,
mice were chosen randomly for killing, but
at weeks 57 and 70 mice that were
comparatively less sick were selected. (A)
and (B), mice that were less unwell.
(A) · 110, lungs had a lesser amount of
mycobacterial antigen (detected by
a-bacillus Calmette–Gue´rin [a-BCG]
polyclonal antiserum) compared with the
moribund mice. (B) · 424, cells with a
moderate intensity of stain predominated.
(C–H), moribund mice. (C) · 114, a greater
amount of mycobacterial antigen compared
with mice that were less unwell. (D) · 422,
cells with strong intensity of stain
predominated. (E) · 200, the necrotic foci
contained a large amount of antigen.
(F) · 416, the bronchiolar lumen containing
cellular debris also contained antigens.
(G) · 110, a very high amount of ManLAM
was detected in frozen sections compared
with paraffin-embedded sections.
Deparaffinization of tissues might have
resulted in the removal of lipids. (H) · 110,
the level of MPT64 (secretory
Mycobacterium tuberculosis antigen) was
less than LAM.
Fig. 7. Colony-forming units (CFU) of
Mycobacterium tuberculosis in (X) lung
(S) spleen and (W) liver tissue of mice
with slowly progressive primary
tuberculosis. In each group, n ¼ 3 or 4
mice. Bars indicate the standard error
of the mean (SEM). At each time-point,
mice were chosen randomly for killing,
but at weeks 57 and 70, mice that were
comparatively less sick were selected.
After week 40, the differences in CFUs
between moribund (weeks 41 and 52) and
mice that were less sick (weeks 57 and 70)
was significant (P ¼ 0.001).Weeks after infection
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morphology of lesions (T. Mustafa, S. Phyu, R. Nilsen: manu-
script in preparation).
During the third phase there was a variation in the degree to
which the mice were unwell. The majority of the mice were
moribund but some mice were less unwell. At weeks 57 and 70,
the mice that were less unwell were selected for comparison with
moribund mice at weeks 41 and 52. The moribund mice had a
significantly higher level of mycobacterial antigens and bacteria
in the lungs compared with the healthier mice. Some of the
moribund mice had focal areas of necrosis whereas no necrotic
foci were found in the mice that were less unwell, even though in
both groups the lesions occupied < 80% of the lung parenchyma.
The clinical variations seen in mice have a resemblance to
human TB where the prognosis of sputum-positive individuals
varies. Without chemotherapy, 50% of the diseased individuals
die, 30% are self-cured and the remaining 20% remain alive but
are infectious [32,33].
Expansion of vacuolated macrophages coincided with the
progression from subclinical infection to disease and from
disease to mortality. Both these shifts were associated with an
increase in the size of macrophage aggregates, thereby indicating
at an association of vacuolated macrophages with immuno-
pathology. From their morphological appearance, these macro-
phages seem to have increased secretory activity. During phase
3, the lymphocyte aggregates decreased in size, whereas there
was an increase in the number of vacuolated macrophages. In the
moribund mice, the lymphocyte aggregates almost disappeared
and the individual lymphocytes were found scattered between
macrophages. There is evidence that apoptosis of T cells from
TB patients is increased compared with healthy control subjects
[34]. Mycobacterial antigens were detected in only 5% of the
vacuolated macrophages. Presumably these antigen-containing
macrophages play a key role in providing a continuous antigen
stimulus, eliciting the cytokine production leading to an expansion
of the lesions.
LAM was the major antigen detected in the macrophages
(Fig. 6G). LAM can deactivate macrophages by blocking the
production of H2O2, nitric oxide and tumour necrosis factor-a
(TNF-a) [35,36]. LAM can also block the activation of macro-
phages via interferon-g (IFN-g) by inhibiting the transcription of
IFN-g-inducible genes [37] and induces the release of transform-
ing growth factor-b (TGF-b) from human monocytes [38], which
deactivates the mycobactericidal functions of macrophages
[39,40].
In humans, subsequent to infection there is formation of a
‘primary complex’ in the majority of individuals [1]. Progression
of infection to disease in < 10% of the infected individuals [1,2]
is presumably because the granulomas in these individuals are
unable to contain the infection. This resembles the situation of
small, mixed granulomas during the first phase of infection in our
model. Further study of our model may help to understand the
risk factors for progression of infection to primary disease in
humans. One risk factor was the high dose of infection and,
consequently, the number of bacilli initially present in the lungs.
This is evident when we compare this model of slowly progressive
TB with our previous models of latent infection and rapidly
progressive disease [12].
The histopathological findings in our model are consistent
with those of Dunn & North [9,10] and Rhoades et al. [11] in
several regards. Fibrosis is suggested to play a key role in the
pathogenesis of slowly progressive primary TB [10]. In our study,
fibroblasts were present in the lesions throughout the course of
infection and increased in number with the shift to phase 3. No
striking increase in the collagen or reticular fibres were, however,
seen with the progression of pathology in phase 3.
In conclusion, 1.5 · 106 CFU of H37Rv given i.p. to mice
resulted in slowly progressive primary TB, which passed through
three distinctive phases, resembling human primary TB. The first
phase was characterized by subclinical infection, development of
small granulomas and an increase in CFUs. During the second
phase, mice developed signs of disease. The granulomas
increased in size and contained more vacuolated macrophages.
CFUs and granuloma size remained stable. The third phase was
characterized by increased mortality and a sudden loss of the
granulomatous nature of the lesions and spread of inflammatory
infiltrates in most of the lung parenchyma without any substantial
increase in the CFUs. The increase in morbidity and mortality
appears to occur as a result of sudden changes in the host immune
response, rather than because of an increase in CFUs.
ACKNOWLEDGMENTS
The authors are grateful to Dr Morten Harboe at the Institute of
Immunology and Rheumatology (University of Oslo, Oslo,
Norway), for providing the a-LAM and a-MPT64 antisera and
for useful advice. We acknowledge Øyunn Nielsen at the
Laboratory for Oral Microbiology (Faculty of Dentistry, Uni-
versity of Bergen) and Eirik Røynstrand at the Department of
Pathology (Haukeland University Hospital) for providing tech-
nical assistance, and thank Gry Bernes and Hilda Emilia
Azevedo Andersen for providing excellent technical assistance
in animal care. Special thanks are given to Kathrine Skarstein
for help with the image-processing system, to Rune Daniel
Haakonsen for help with the photographs, to Valborg Baste for
statistical advice and to Carla Olsnes for proofreading the manu-
script. This study was supported by the European Commission
(Grant ERBIC 18CT960060) and a research grant from the
University of Bergen, Norway.
REFERENCES
1 Roger MDP, Craig RH. Mycobacterium tuberculosis. In: Mandell GL,
Douglas RG Jr, Bennett JE, eds. Principles and Practice of Infectious
Diseases. New York: Churchill Livingstone, 1990: 1877–906.
2 Styblo K. Recent advances in epidemiological research in tubercu-
losis. Adv Tuberc Res 1980;20:1–63.
3 Gedde-Dahl T. Tuberculosis infection in the light of tuberculin
matriculation. Am J Hygiene 1951;56:139–214.
4 Sutherland I. Recent studies in the epidemiology of tuberculosis,
based on the risk of being infected with tubercle bacilli. Adv Tuberc
Res 1976;19:1–63.
Slowly Progressive Murine Tuberculosis 135
q 1999 Blackwell Science Ltd, Scandinavian Journal of Immunology, 50, 127–136
5 Medical Research Council. BCG and whole bacillus vaccines in the
prevention of tuberculosis in adolescence and early adult life. Bull
WHO 1972;46:371–85.
6 Nyka W, Faherty JF, Malone LC, Kiser JS. A histological study of
the pathogenesis of tuberculosis in mice experimentally infected
with bacilli of human type. Exp Med Surg 1954;12:367–429.
7 Raleigh GW, Youmans GP. The use of mice in experimental
chemotherapy of tuberculosis: II. Pathology and pathogenesis. J
Infect Dis 1948;82:205–20.
8 Andersen P, Heron I. Specificity of a protective memory immune
response against Mycobacterium tuberculosis. Infect Immun
1993;61:844–51.
9 Dunn PL, North RJ. Persistent infection with virulent but not
avirulent Mycobacterium tuberculosis in the lungs of mice causes
progressive pathology. J Med Microbiol 1996;45:103–9.
10 Dunn PL, North RJ. Virulence ranking of some Mycobacterium
tuberculosis and Mycobacterium bovis strains according to their
ability to multiply in the lungs, induce lung pathology, and cause
mortality in mice. Infect Immun 1995;63:3428–37.
11 Rhoades ER, Frank AA, Orme IM. Progression of chronic pulmon-
ary tuberculosis in mice aerogenically infected with virulent Myco-
bacterium tuberculosis. Tuberc Lung Dis 1997;78:57–66.
12 Phyu S, Mustafa T, Hofstad T, Nilsen R, Fosse R, Bjune G. A mouse
model for latent tuberculosis. Scand J Infect Dis 1998;30:59–68.
13 Spencer J, Gyre LA, Hall JG. IgA antibodies in the bile of rats. III.
The role of intrathoracic lymph nodes and the migration pattern of
their blast cells. Immunology 1981;48:687–93.
14 Courtice FC, Simmonds WJ. Physiological significance of lymph
drainage of the serous cavities and lungs. Physiol Rev 1954;34:419–
85.
15 Yoffey JM, Courtice FC. Lymph flow from regional lymphatics. In:
Yoffey JM, Courtice FC, eds. Lymphatices, Lymph and the Lym-
phomyeloid Complex. London: Academic Press, Inc., 1970: 295–9.
16 Olin T, Saldeen T. The lymphatic pathways from peritoneal cavity: a
lymphoangiographic study in the rats. Cancer Res 1964;24:1700–11.
17 Buxton BH, Torrey JC. Absorption from the peritoneal cavity. J Med
Res 1906;15:5–87.
18 Lefford MJ. Diseases in the mice and rats. In: Kubica GP, Wayne
LG, eds. The Mycobacteria—a Source Book. New York: Marcel
Dekker, 1984: 947–74.
19 Orme IM, Collins FM. Mouse model of tuberculosis. In: Bloom BR,
ed. Tuberculosis: Pathogenesis, Protection, and Control. Washing-
ton, DC: ASM Press, 1995: 113–34.
20 Sweat F, Puchtler H, Rosenthal SI. Sirius Red F3BA as a stain for
connective tissue. Arch Pathol 1964;78:69–72.
21 Nagai S, Wiker HG, Harboe M, Kinomoto M. Isolation and partial
characterization of major protein antigens in the culture fluid of
Mycobacterium tuberculosis. Infect Immun 1991;59:372–82.
22 Harboe M, Closs O, Bjorvatn B, Kronvall G, Axelsen NH. Antibody
response in rabbits to immunization with Mycobacterium leprae.
Infect Immun 1977;18:792–805.
23 Harboe M, Closs O, Svindahl K, Deverill J. Production and assay of
antibodies against one antigenic component of Mycobacterium bovis
BCG. Infect Immun 1977;16:662–72.
24 Venisse A, Berjeaud JM, Chaurand P, Gilleron M, Puzo G. Structural
features of lipoarabinomannan from Mycobacterium bovis BCG.
Determination of molecular mass by laser desorption mass spectro-
metry. J Biol Chem 1993;268:12401–11.
25 Closs O, Harboe M, Axelsen NH, Bunch-Christensen K, Magnussen
M. The antigens of Mycobacterium bovis, strain BCG, studied by
crossed immunoelectrophoresis: a reference system. Scand J Immunol
1980;12:246–63.
26 Wiley EL, Mulhollan TJ, Beck B, Tyndall JA, Freemann RG.
Polyclonal antibodies raised against bacillus Calmette-Guerin,
Mycobacterium duvalii and Mycobacterium paratuberculosis used
to detect mycobacteria in tissues with the use of immunohistochemical
techniques. Am J Clin Pathol 1990;94:307–12.
27 Wiker HG, Harboe M, Bennedsen J, Closs O. The antigens of
Mycobacterium tuberculosis, H37Rv, studied by crossed immunoe-
lectrophoresis. Comparison with a reference system for Mycobacter-
ium bovis, BCG. Scand J Immunol 1988;27:223–39.
28 Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed,
paraffin-embedded tissues: an enhancement method for immunohis-
tochemical staining based on microwave oven heating of tissue
sections. J Histochem Cytochem 1991;39:741–8.
29 Shi SR, Chaiwun B, Young L, Cote RJ, Taylor CR. Antigen
retrieval technique utilizing citrate buffer or urea solution for
immunohistochemical demonstration of androgen receptor in for-
malin-fixed paraffin sections. J Histochem Cytochem 1993;41:
1599–604.
30 Mighell AJ, Robinson PA, Hume WJ. Patterns of immunoreactivity
to an anti-fibronectin polyclonal antibody in formalin-fixed, paraffin-
embedded oral tissues are dependent on methods of antigen retrieval.
J Histochem Cytochem 1995;43:1107–14.
31 Kaplan EL, Meier P. Non parametric estimation from incomplete
observations. J Am Stat Assoc 1958;53:457–81.
32 Springett VH. Tuberculosis control in Britian 1945–1970–1985.
Tubercle 1971;52:136–47.
33 National Tuberculosis Institute. Tuberculosis in a rural population in
South India: a five year epidemiological study. Bull WHO
1974;51:473–88.
34 Hirsch CS, Toosi Z, Vanham G et al. A role of apoptosis in
suppressed T-cell responses in patients with tuberculosis in
Uganda. Tuberc Lung Dis 1997;78:75–84.
35 Chatterjee D, Roberts AD, Lowell K, Brennan PJ, Bloom BR.
Structural basis of capacity of lipoarabinomannan to induce
tumour necrosis factor. Infect Immun 1992;60:1249–53.
36 Adams LB, Fukutomi Y, Krahenbuhl JL. Regulation of murine
macrophage effector functions by lipoarabinomannan from myco-
bacterial strains with different degrees of virulence. Infect Immun
1993;61:4173–81.
37 Chan J, Fan X, Hunter SW, Brennan PJ, Bloom BR. Lipoarabino-
mannan, a possible virulence factor involved in persistence of
Mycobacterium tuberculosis within macrophages. Infect Immun
1991;59:1755–61.
38 Dahl KE, Shiratsichi H, Hamilton BD, Ellner JJ, Toosi Z. Selective
induction of transforming growth factor in human monocytes by
lipoarabinomannan of Mycobacterium tuberculosis. Infect Immun
1996;64:399–405.
39 Ding A, Nathan CF, Graycar J, Derynck R, Stuhr DJ, Srimal S.
Macrophage deactivating factor and transforming growth factor beta
1, 2 and 3 inhibit induction of macrophage nitrogen oxide synthesis
by IFN gamma. J Immunol 1990;145:940–4.
40 Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of
macrophages by transforming growth factor b. Nature 1988;334:
260–2.
136 T. Mustafa et al.
q 1999 Blackwell Science Ltd, Scandinavian Journal of Immunology, 50, 127–136
